Maintenance hemodialysis in myeloma kidney disease.
Maintenance hemodialysis and chemotherapeutic agents were used in the treatment of seven patients with end-stage myeloma kidney disease. Results indicate that with the use of such therapy life can be prolonged substantially. It appears that patients with myeloma-with or without serious extrarenal complications-are suitable candidates for maintenance hemodialysis and should not be denied the treatment even in the face of systemic neoplasm.
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D006435:Renal Dialysis; D014511:Uremia / Q000150:complications / Q000628:therapy*